The J.M. Smucker Company
SJM
$118.32
+2.26%
The J.M. Smucker Company is a packaged food company that primarily sells through the U.S. retail channel, with leading brands in coffee (Folgers, Dunkin'), pet foods (Milk-Bone, Meow Mix), and frozen handhelds/spreads (Jif, Smucker's, Uncrustables), and has expanded into sweet baked snacks via the Hostess acquisition. As a diversified consumer staples player, Smucker holds strong market positions across multiple categories, particularly in coffee and pet snacks, where its brands are household names. The current investor narrative centers on the company's ability to drive growth through pricing actions in coffee, the integration of Hostess, and margin recovery after a period of impairment charges, with recent Q4 earnings beating expectations but a cautious sales outlook tempering enthusiasm.…
SJM
The J.M. Smucker Company
$118.32
Related headlines
Investment Opinion: Should I buy SJM Today?
Rating: Hold. The thesis is that SJM offers a compelling value play with a strong Q4 earnings beat and attractive valuation, but cautious guidance and debt overhang limit near-term upside, warranting a hold for current investors and a cautious buy for new ones. The consensus analyst rating is Buy with an average target of $123.94, implying 4.8% upside.
Supporting evidence: (1) Forward P/E of 11.05x is a 39% discount to the industry average of 18x. (2) Q4 revenue grew 5.8% YoY to $2.268 billion, with gross margin expanding 310 bps to 41.5%. (3) TTM free cash flow of $1.156 billion supports a 4.4% dividend yield. (4) The P/S ratio of 1.16x is near the low end of its five-year range of 1.0x-2.5x, suggesting historical undervaluation. However, the negative trailing net margin (-1.5%) and cautious FY2027 revenue guidance ($9.07 billion midpoint) temper enthusiasm.
Risks & conditions: The biggest risks are (1) failure to sustain margin improvement, (2) rising coffee costs, and (3) slower Hostess integration. This Hold would upgrade to Buy if forward P/E compresses below 10x or if FY2027 guidance is raised, and downgrade to Sell if revenue growth decelerates below 3% or gross margin falls below 38%. Valuation verdict: SJM is undervalued relative to peers and its own history on a P/S and forward P/E basis, but the discount reflects execution risks and a cautious outlook.
Sign up to view all
SJM 12-Month Price Forecast
SJM's outlook is balanced: the Q4 earnings beat and attractive valuation provide a floor, but cautious guidance and debt overhang cap upside. The base case of steady performance and modest multiple expansion is most likely (50% probability), with the stock trading in the $115-$125 range. A bull case (25%) requires sustained margin improvement and successful Hostess integration, while a bear case (25%) could materialize from cost inflation or demand weakness. The neutral stance reflects the tension between value and execution risk; an upgrade to bullish would require evidence of accelerating revenue growth or margin expansion above 42%, while a downgrade to bearish would follow a miss on earnings or guidance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The J.M. Smucker Company's 12-month outlook, with a consensus price target around $123.94 and implied upside of +4.8% versus the current price.
Average Target
$123.94
0 analysts
Implied Upside
+4.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$102 - $135
Analyst target range
SJM is covered by 16 analysts, with a consensus recommendation of 'Buy' (mean rating 2.11 on a 1-5 scale, where 1 is Strong Buy). The average target price is $123.94, implying approximately 4.8% upside from the current price of $118.32. The distribution leans bullish, with recent ratings from Barclays (Equal Weight), UBS (Buy), Wells Fargo (Overweight), and JP Morgan (Overweight) reaffirmed after the Q4 earnings release. The target range spans from a low of $102.00 to a high of $135.00. The high target of $135 assumes successful margin expansion, continued pricing power in coffee, and full realization of Hostess synergies, potentially driving multiple expansion. The low target of $102 reflects risks of input cost inflation, competitive pressure, or a slower-than-expected recovery in profitability. The spread between low and high is $33, or 28% of the average target, indicating moderate uncertainty. Recent analyst actions have been largely reaffirmations rather than upgrades or downgrades, suggesting stability in sentiment. The consensus implies cautious optimism, with the stock trading near the lower end of the target range, offering limited upside but supported by a defensive business model and improving fundamentals.
Bulls vs Bears: SJM Investment Factors
SJM presents a mixed picture: the bull case rests on a strong Q4 earnings beat, attractive valuation relative to peers and history, robust free cash flow, and a defensive business model. The bear case highlights negative trailing margins, cautious guidance, elevated debt, limited upside to analyst targets, and coffee segment concentration. Currently, the bull side has stronger evidence given the Q4 turnaround and valuation discount, but the cautious outlook and debt overhang temper enthusiasm. The single most important tension is whether the earnings recovery seen in Q4 is sustainable—if margins continue to expand and revenue growth holds, the stock could re-rate higher; if input costs rise or consumer spending weakens, the recovery could stall, validating the bear case.
Bullish
- Strong Q4 Earnings Beat: Q4 FY2026 net income surged to $388.1 million from a loss of $729 million a year ago, driven by pricing actions in coffee and cost savings. Gross margin improved to 41.5% from 38.4%, signaling a sharp profitability recovery.
- Attractive Valuation vs. Peers: SJM trades at a forward P/E of 11.05x and a P/S of 1.16x, well below the packaged foods industry averages of ~18x and ~1.5x, respectively. This discount of 39% on earnings and 23% on sales suggests undervaluation if earnings recovery materializes.
- Strong Free Cash Flow Generation: TTM free cash flow stands at $1.156 billion, providing ample coverage for dividends (4.4% yield) and debt reduction. This cash generation supports financial flexibility despite a current ratio of 0.78.
- Consensus Buy Rating with Upside: 16 analysts rate SJM a Buy (mean 2.11 on 1-5 scale), with an average target of $123.94, implying 4.8% upside. The high target of $135 suggests 14% potential, contingent on margin expansion and Hostess synergies.
Bearish
- Negative Trailing Net Margin: TTM net margin is -1.5% due to impairment charges in prior quarters, and operating margin is only 4.0%. While Q4 showed improvement, profitability remains under pressure from high input costs and debt service.
- Cautious Sales Outlook: Despite Q4 revenue growth of 5.8% YoY, the company's guidance for FY2027 is cautious, with estimated revenue of $9.07 billion (midpoint) implying deceleration. This tempers the bullish case and suggests limited top-line momentum.
- Elevated Debt Levels: Debt-to-equity of 1.28 and total debt of $4.37 billion (43.7% of assets) indicate moderate leverage. Interest expense of $87.9 million in Q4 consumes a significant portion of operating income, constraining earnings growth.
- Limited Near-Term Upside to Targets: At $118.32, SJM trades near the lower end of the analyst target range ($102-$135) and only 4.8% below the average target. This limited upside suggests the stock may already price in much of the recovery optimism.
SJM Technical Analysis
SJM is in a strong recovery uptrend, with the stock up 8.9% over the past year and currently trading at $118.32, near the top of its 52-week range of $88.25 to $119.39, at 99.1% of the high. This positioning near the 52-week high suggests bullish momentum and market confidence, though it also raises the risk of overextension. The stock has rebounded sharply from its 52-week low of $88.25 in April 2026, reflecting a sustained recovery. Short-term momentum is accelerating, with a 1-month gain of 6.0% and a 3-month gain of 23.2%, outpacing the S&P 500's 0.8% and 3.5% returns over the same periods, respectively. The relative strength over 3 months is a robust 19.7%, indicating strong outperformance. However, the 1-year relative strength is -7.6%, suggesting the longer-term trend has lagged the market, and the recent surge may represent a catch-up or mean reversion. Key support is at the 52-week low of $88.25, while resistance is at the 52-week high of $119.39. A breakout above $119.39 would signal a new uptrend and likely attract momentum buyers, while a breakdown below $88.25 could indicate a return to weakness. With a beta of 0.25, SJM is significantly less volatile than the market, making it a defensive holding, but the recent price action shows it can still experience sharp moves.
Beta
0.25
0.25x market volatility
Max Drawdown
-22.8%
Largest decline past year
52-Week Range
$88-$119
Price range past year
Annual Return
+8.9%
Cumulative gain past year
| Period | SJM Return | S&P 500 |
|---|---|---|
| 1m | +6.0% | +1.4% |
| 3m | +23.2% | +3.3% |
| 6m | +15.4% | +6.3% |
| 1y | +8.9% | +16.0% |
| ytd | +22.4% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SJM Fundamental Analysis
Revenue has been growing, with the most recent quarter (Q4 FY2026, ended April 30, 2026) reporting $2.268 billion, up 5.8% year-over-year. However, the multi-quarter trend shows variability: Q3 FY2026 revenue was $2.339 billion (down from $2.186 billion in Q3 FY2025), while Q2 FY2026 was $2.330 billion. The growth is driven by pricing actions in coffee, which is the largest segment at 32% of sales, and the Hostess acquisition. The coffee segment alone generated $2.735 billion in revenue, while pet foods contributed $1.183 billion. The revenue growth trajectory is positive but decelerating from the double-digit gains seen in prior years, and the company's guidance suggests a cautious outlook for FY2027. Profitability has been mixed. The company reported net income of $388.1 million in Q4 FY2026, a sharp turnaround from a net loss of $729 million in Q4 FY2025, which was impacted by impairment charges. Gross margin improved to 41.5% in Q4 FY2026 from 38.4% a year ago, reflecting pricing and cost savings. However, the trailing twelve-month net margin is negative at -1.5%, and the operating margin is just 4.0%, indicating that profitability remains under pressure from high input costs and debt service. The balance sheet shows moderate leverage, with a debt-to-equity ratio of 1.28 and total debt of $4.37 billion (based on debt ratio of 43.7% of assets). Free cash flow generation is strong, with TTM free cash flow of $1.156 billion, providing ample coverage for dividends and debt reduction. The current ratio of 0.78 indicates tight liquidity, but the company's consistent cash flow from operations ($579.2 million in Q4 alone) supports its financial flexibility. ROE is negative at -2.5% due to the trailing net loss, but on a normalized basis, ROE has historically been in the mid-single digits.
Quarterly Revenue
$2.3B
2026-04
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
41.5%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SJM Overvalued?
Since net income is negative on a trailing basis (TTM net margin -1.5%), the price-to-sales (PS) ratio is the most appropriate valuation metric. The trailing PS ratio is 1.16x, while the forward PE (based on positive expected earnings) is 11.05x. The gap between the negative trailing PE and the forward PE of 11.05x implies the market expects a significant earnings recovery, which is consistent with the recent Q4 beat and guidance for improved profitability. Compared to the packaged foods industry average PS of approximately 1.5x (based on typical sector multiples), SJM's PS of 1.16x represents a 23% discount, suggesting the stock is undervalued relative to peers on a sales basis. However, the forward PE of 11.05x is below the industry average of around 18x, indicating a 39% discount, which may reflect skepticism about the sustainability of earnings recovery or concerns about debt. Historically, SJM's trailing PE has ranged from -75x to 55x over the past five years, with the current negative PE near the bottom of its historical band due to impairment-driven losses. The PS ratio of 1.16x is near the low end of its five-year range of 1.0x to 2.5x, suggesting the stock is cheap relative to its own history, which could indicate a value opportunity if the earnings recovery materializes as expected.
PE
-75.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: SJM's balance sheet carries moderate leverage with a debt-to-equity ratio of 1.28 and total debt of $4.37 billion, leading to quarterly interest expenses of ~$88 million that pressure net income. The trailing net margin of -1.5% and operating margin of just 4.0% highlight profitability challenges, though Q4 FY2026 showed improvement with gross margin rising to 41.5%. Free cash flow of $1.156 billion provides a cushion, but the current ratio of 0.78 indicates tight liquidity, requiring continued operational discipline to avoid financial strain. Revenue concentration in coffee (32% of sales) exposes the company to commodity price swings and changing consumer preferences, while the Hostess acquisition integration adds execution risk.
Market & Competitive Risks: SJM trades at a forward P/E of 11.05x, a 39% discount to the industry average of 18x, which could reflect skepticism about earnings sustainability. If the recovery disappoints, the stock could de-rate further, especially given its low beta of 0.25 that limits upside participation in market rallies. Competitive pressures from private-label brands and larger players like Nestlé and General Mills could erode market share in coffee and pet foods. Recent news highlights struggles at peer Conagra, underscoring sector headwinds from inflation and shifting consumer behavior, which could spill over to SJM.
Worst-Case Scenario: A combination of rising coffee bean costs, slower-than-expected Hostess synergy realization, and a consumer spending downturn could cause SJM to miss earnings estimates, leading to analyst downgrades and multiple compression. In this scenario, the stock could fall to its 52-week low of $88.25, representing a -25.4% decline from the current price of $118.32. The analyst low target of $102 implies a -13.8% downside, but a severe recession or input cost shock could push the stock below that level, approaching the historical low.
FAQ
The key risks are: (1) Financial risk from high debt (debt-to-equity 1.28, interest expense $88M/quarter) which could strain earnings if margins don't improve. (2) Competitive risk in coffee (32% of sales) from private-label brands and commodity price volatility—a 20% spike in coffee beans could reduce gross margins by 200 bps. (3) Macro risk from a consumer recession, which could pressure volumes and delay the earnings recovery—SJM's low beta (0.25) offers some protection but doesn't eliminate demand risk. (4) Company-specific risk from Hostess integration—if synergies fall short, the acquisition could become a drag on returns. The most severe risk is a combination of rising costs and falling volumes, which could push the stock to the 52-week low of $88.25, a -25.4% downside from current levels.
The 12-month forecast is mixed, with three scenarios: Bull case (25% probability) targets $125-$135, driven by sustained margin expansion and Hostess synergies; Base case (50% probability) targets $115-$125, with steady performance and modest multiple expansion; Bear case (25% probability) targets $88-$102, from cost inflation or demand weakness. The most likely scenario is the base case, where SJM trades near the analyst average target of $123.94, implying ~4.8% upside. Key assumptions for the base case include revenue growth of 3-4%, gross margin around 40-41%, and no major impairment charges. The forecast is highly dependent on the trajectory of coffee costs and consumer spending, which will be clarified in upcoming quarterly reports.
SJM appears undervalued relative to both peers and its own history. The trailing P/S ratio of 1.16x is near the low end of its five-year range of 1.0x-2.5x, and the forward P/E of 11.05x is a 39% discount to the packaged foods industry average of 18x. The negative trailing P/E (-75x) is due to impairment charges, but the forward P/E based on expected earnings of $11.44 per share suggests the market is pricing in a recovery. Compared to peers like General Mills (forward P/E ~15x) and Kellogg (~14x), SJM trades at a significant discount, likely reflecting its higher debt and recent earnings volatility. The valuation implies the market expects the earnings recovery to materialize but remains skeptical about sustainability. Overall, SJM is undervalued on a forward basis, but the discount is warranted by execution risks.
SJM is a reasonable buy for value and income investors, given its 4.4% dividend yield, strong free cash flow of $1.156 billion, and valuation discounts (forward P/E 11.05x vs industry 18x). The consensus analyst target of $123.94 implies 4.8% upside, but the cautious FY2027 guidance limits near-term appreciation. The biggest downside risk is a failure to sustain margin improvement, which could send the stock to the 52-week low of $88.25 (-25.4%). For long-term investors with a 3-5 year horizon, the current price offers a margin of safety; for short-term traders, the limited upside and low beta make it less attractive. Overall, it's a good buy for those seeking stable income and value, but not for those seeking rapid growth.
SJM is better suited for long-term investment due to its defensive nature (beta 0.25), high dividend yield (4.4%), and value-oriented profile. The stock's low volatility and stable cash flows make it a good fit for income-focused portfolios with a holding period of 3-5 years or more. Short-term trading is less attractive given the limited upside to analyst targets (4.8%) and the stock's low beta, which means it may not participate strongly in market rallies. However, the recent 23% gain over 3 months shows it can have sharp moves, but these are often mean-reverting. For long-term investors, the current valuation discount provides a margin of safety, and the dividend offers a steady return while waiting for earnings recovery. A minimum holding period of 2-3 years is recommended to allow the recovery thesis to play out.